Compugen Ltd. (CGEN) Logo

    Compugen Ltd. (CGEN) symbol, logo with name and high resolution download options.

    Compugen Ltd. (CGEN) logo

    Sector

    Healthcare

    Industry

    Biotechnology

    Ticker

    CGEN

    Website

    cgen.com

    About Compugen Ltd. (CGEN)

    Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company’s pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been evaluated for the treatment of solid tumors as a monotherapy and in combination of PVRIG/PD-1 and PVRIG/TIGIT, as well as PVRIG/PD-1/TIGIT blockade; Bapotulimab, a therapeutic antibody targeting ILDR2 that is evaluated in Phase I clinical trials in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase III clinical study in patients with advanced or metastatic non-small cell lung cancer. Its preclinical therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb’s PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and Gilead Sciences, Inc. for the research, development, manufacturing, and commercialization of COM503 and other products. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.

    ISIN: IL0010852080
    Ticker: CGEN.TA
    Ticker: CW9
    Ticker: CGEN

    Get Compugen Ltd. (CGEN) Logo via API

    Integrate this logo into your application with a single API call

    GET https://api.logostream.dev/stocks/symbol/CGEN?key=YOUR_API_KEY&variant=icon

    Why Use Our Stock Logo API?

    Fast Delivery

    <100ms response time via global CDN

    Enterprise-Ready

    99.99% uptime SLA with GDPR compliance

    Multiple Formats

    SVG, PNG, WebP - scalable to any size

    400k+ Logos

    Stocks, ETFs, Crypto, Banks, and more

    Where to Use Stock Logos

    Trading Platforms

    Real-time stock displays with instant logo loading

    Portfolio Apps

    Visualize holdings with recognizable brand logos

    Financial Dashboards

    Enhance market data with company branding

    News & Research

    Illustrate articles with accurate company logos

    Frequently Asked Questions

    Use our Stock Logo API with the ticker symbol CGEN. Make a GET request to https://api.logostream.dev/stocks/symbol/CGEN?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

    The Compugen Ltd. (CGEN) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

    With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

    Simply embed the API URL as an image source in your application. For example: <img src="https://api.logostream.dev/stocks/symbol/CGEN?key=YOUR_API_KEY" />. The API returns optimized images with proper caching headers for fast loading.

    Need Stock Logos for Your Application?

    Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.